Serum Glutathione in Patients with Schizophrenia in Dynamics of Antipsychotic Therapy; Bulletin of Experimental Biology and Medicine; Vol. 160, iss. 2

Serum Glutathione in Patients with Schizophrenia in Dynamics of Antipsychotic Therapy; Bulletin of Experimental Biology and Medicine; Vol. 160, iss. 2

Manylion Llyfryddiaeth
Parent link:Bulletin of Experimental Biology and Medicine: Scientific Journal
Vol. 160, iss. 2.— 2016.— [P. 283–285]
Awdur Corfforaethol: Национальный исследовательский Томский политехнический университет Институт неразрушающего контроля Кафедра экологии и безопасности жизнедеятельности
Awduron Eraill: Ivanova S. A. Svetlana Aleksandrovna, Smirnova L. P., Shchigoreva Y. G. Yuliya Gennadjevna, Semke A. V. Arkady Valentinovich, Bokhan N. A. Nikolay Aleksandrovich
Crynodeb:Title screen
Serum concentrations of oxidized and reduced glutathione were measured in 73 patients with schizophrenia at admission and in dynamics of therapy with traditional and atypical antipsychotic drugs. The level of reduced glutathione in patients with schizophrenia with manifest clinical symptoms was lower than in normal subjects. Atypical neuroleptics produced virtually no effects on the glutathione system, while therapy with typical antipsychotics led to further decrease in the levels of reduced glutathione, thus aggravating the imbalance of metabolic processes typical of schizophrenia.
Режим доступа: по договору с организацией-держателем ресурса
Iaith:Saesneg
Cyhoeddwyd: 2016
Pynciau:
электронный ресурс
труды учёных ТПУ
Mynediad Ar-lein:http://dx.doi.org/10.1007/s10517-015-3151-y
Fformat: Electronig Pennod Llyfr
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=649823

Eitemau Tebyg

Eitemau Tebyg